1. Home
  2. CYTK vs GBCI Comparison

CYTK vs GBCI Comparison

Compare CYTK & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$61.52

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Glacier Bancorp Inc.

GBCI

Glacier Bancorp Inc.

HOLD

Current Price

$43.32

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
GBCI
Founded
1997
1955
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.3B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
GBCI
Price
$61.52
$43.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
5
Target Price
$88.50
$53.60
AVG Volume (30 Days)
1.8M
947.9K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
18.45
EPS
N/A
1.99
Revenue
$13,368,000.00
N/A
Revenue This Year
$8.73
$31.62
Revenue Next Year
$309.93
$8.37
P/E Ratio
N/A
$21.58
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$36.76
52 Week High
$70.98
$53.99

Technical Indicators

Market Signals
Indicator
CYTK
GBCI
Relative Strength Index (RSI) 45.86 35.54
Support Level $59.13 $42.78
Resistance Level $65.72 $43.90
Average True Range (ATR) 2.57 1.28
MACD 0.03 -0.11
Stochastic Oscillator 49.44 32.97

Price Performance

Historical Comparison
CYTK
GBCI

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: